U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215273) titled 'Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections' on Sept. 24.
Brief Summary: The purpose of this study is to determine if EL219 is safe and effective compared to the standard of care for early treatment of suspected invasive mould infection.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Suspected Invasive Mould Infection
Intervention:
DRUG: EL219
EL219 is specifically being developed for early antifungal therapy (EAT), when infection is suspected due to highly suggestive signs and symptoms of disease; in high-risk people, antifungals are recommended e...